Head-to-head · WeighScore
No BS RX vs Nurx
By GLP-1 ScorecardUpdated
Score comparison
No BS RX has the higher recorded score — 82.8/100 to 66.5/100.
No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. No BS RX publishes separate prices for standard compounded, low-dose and brand-name programs.
Before you choose
Before comparing the headline prices, the No BS RX review and the Nurx review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, No BS RX vs NuuVim and Nurx vs RxSaludable compare each of them with another graded program, and the list of alternatives to No BS RX ranks the programs closest to No BS RX on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Direct Meds review covers one graded close to these two, at 77.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | No BS RX | Nurx |
|---|---|---|
| WeighScore | 82.8/100 | 66.5/100 |
| Grade | B− | C |
| Site position | #23 | #202 |
| Semaglutide | $149/mo advertised for standard compounded injection; low-dose priced separately | Branded Wegovy pharmacy quote plus separate $79 initial consult and $79/mo support |
| Tirzepatide | $225/mo advertised for standard compounded injection; low-dose priced separately | Branded Zepbound pharmacy quote plus separate $79 initial consult and $79/mo support |
| Coverage | Confirm program availability for your state | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Displays monthly and prepaid amounts by program
- Advertises consultation, medication, shipping and messaging in the compounded plans
- Lists branded Ozempic and Zepbound separately
What to consider
- The $115 headline applies to low-dose programs
- Plans renew automatically at the then-current rate
- Cancellation generally stops future billing without refunding the current period
Strengths
- Publishes the initial and recurring care fees
- Lists branded Wegovy and Zepbound as local-pharmacy options
What to consider
- The care fees are paid out of pocket
- Insurance approval and the medication price depend on your prescription and plan
- Confirm the next billing date and refund terms
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.